Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
D015115:5,6-Dihydroxytryptamine / Q000031:analogs & derivatives / Q000494:pharmacology; D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000311:Adrenal Glands / Q000187:drug effects / Q000201:enzymology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001971:Bromocriptine / Q000494:pharmacology; D002230:Carbidopa / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology; D006892:Hydroxydopamines / Q000008:administration & dosage / Q000494:pharmacology; D007276:Injections, Intraventricular; D007700:Kinetics; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D010891:Piribedil / Q000494:pharmacology; D010902:Pituitary Gland / Q000502:physiology; D051381:Rats; D012701:Serotonin / Q000502:physiology*; D012702:Serotonin Antagonists; D013153:Splanchnic Nerves / Q000502:physiology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D006892:Hydroxydopamines; D012702:Serotonin Antagonists; D012701:Serotonin; D001971:Bromocriptine; D007980:Levodopa; D006916:5-Hydroxytryptophan; D010891:Piribedil; D014446:Tyrosine 3-Monooxygenase; D006220:Haloperidol; D003000:Clonidine; D002230:Carbidopa; D001058:Apomorphine; D004298:Dopamine; D015115:5,6-Dihydroxytryptamine